Exxon Mobil Value Added Proposition

First Page		Document Content
Date: 2012-06-26 09:47:50 Chemistry Pharmacokinetics Pharmacy Toxicology Physiologically based pharmacokinetic modelling Toxicokinetics Biomonitoring Toxicity Quantitative structure–activity relationship Pharmaceutical sciences Medicine Pharmacology		Exxon Mobil Value Added Proposition Add to Reading List Source URL: www.axlr8.eu Download Document from Source Website File Size: 1,44 MB Share Document on Facebook

	Glyphosate Research Scoping Background Materials: NTP Technical Report on Toxicity Studies of Glyphosate (CAS NoAdministered in Dosed Feed to F344/N Rats and B6C3F1 Mice, NTP Toxicity Reports Series No. 16, DocID: 1vr6n - View Document
	IN THIS ISSUE Chemical Reaction Reducing the use of animals in toxicity testing Watershed Moment McDonald’s announces plans to DocID: 1vk7D - View Document
	Low Toxicity Substances If ingested: What to do: These substances are considered to be of low toxicity when ingested acutely. They may cause oral irritation and mild gastrointestinal upset but other features are unlikely DocID: 1vhFH - View Document
	Risk Anulvsis, 5. No. 4, I985 Letter to the Editor Toxicity and Carcinogenic Potency Leslie Bernstein,“) Lois S. Gold,(2) Bruce N. Arnes,(’) Malcolm C. Pike,(3) and David G. DocID: 1vdoU - View Document
	# 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,,#, Stephen M. Shaw 1,, Kim Wi DocID: 1vdls - View Document